Arteris, INC Form 4 insider transactions

Arteris, Inc. Director Joachim Kunkel acquired 910 shares of common stock as fully vested restricted stock, representing deferred retainer fees.

Arteris VP and General Counsel, Paul L. Alpern, executed a planned sale of company stock following option exercise in early 2026.

Arteris, Inc. President and CEO, Charles K. Janac, sold 7,823 shares of common stock on January 2, 2026, to cover tax liabilities from restricted stock unit releases.

Arteris, Inc.'s Chief Operating Officer, Laurent R. Moll, sold common stock on January 2, 2026, to cover tax liabilities from restricted stock unit releases.

Arteris, Inc.'s VP and CFO, Nicholas B. Hawkins, sold common stock to cover tax liabilities from restricted stock unit vesting, while also acquiring shares through an employee plan.

Arteris VP and General Counsel Paul L. Alpern reported the sale of common stock, partially to cover tax liabilities and partially under a pre-arranged 10b5-1 trading plan.

Arteris, Inc.'s Chief Operating Officer, Laurent R. Moll, sold 17,937 shares of common stock for a weighted average price of $18.9615 per share under a pre-arranged trading plan.

Arteris Director Antonio J. Viana sold 20,000 shares of common stock for approximately $18.01 per share under a pre-arranged 10b5-1 trading plan.

Arteris, Inc.'s VP and Chief Financial Officer, Nicholas B. Hawkins, sold 721 shares of common stock for $17.56 per share under a pre-arranged 10b5-1 trading plan.

Arteris, Inc.'s Chief Operating Officer, Laurent R. Moll, sold a total of 35,137 shares of common stock in early December 2025 under a pre-arranged 10b5-1 trading plan.

Bayview Legacy, a 10% owner of Arteris Inc., reported sales of 130,000 common shares totaling approximately $2.29 million under a pre-arranged 10b5-1 trading plan.

Arteris, Inc. President and CEO, Janac K. Charles, reported the sale of 130,000 shares of common stock in early December 2025 through a pre-arranged 10b5-1 trading plan.

Bayview Legacy, LLC, a 10% owner of Arteris, Inc., sold 40,000 shares of common stock for approximately $16.46 per share under a pre-arranged 10b5-1 trading plan.

Arteris Inc.'s VP and General Counsel, Paul L. Alpern, exercised options and subsequently sold 7,500 shares of common stock under a pre-arranged 10b5-1 trading plan.

Arteris, Inc. President and CEO, K. Charles Janac, sold 40,000 shares of common stock for approximately $16.46 per share under a pre-arranged trading plan.

Arteris, Inc.'s VP and Chief Financial Officer, Nicholas B. Hawkins, sold 438 shares of common stock to cover tax obligations from restricted stock unit release.

Arteris, Inc. President and CEO, Janac K Charles, reported sales of common stock totaling 3,304 shares in early December 2025, primarily for tax obligations and under a pre-arranged trading plan.

Arteris, Inc.'s VP and General Counsel, Paul L. Alpern, reported the sale of 683 shares of common stock for tax obligations and under a pre-arranged 10b5-1 trading plan.

Arteris, Inc.'s Chief Operating Officer, Laurent R. Moll, sold a total of 814 shares of common stock in early December 2025, primarily to cover tax liabilities and under a pre-arranged 10b5-1 trading plan.

Arteris, Inc.'s VP and General Counsel, Paul L. Alpern, exercised stock options and subsequently sold 5,000 shares of common stock under a pre-arranged 10b5-1 plan.

Arteris, Inc. President and CEO, Janac K Charles, sold 50,000 shares of common stock for a weighted average price of $14.7366 per share under a pre-arranged 10b5-1 trading plan.

Bayview Legacy, LLC, a 10% owner of Arteris, Inc., reported the sale of 50,000 shares of common stock at a weighted average price of $14.7366.

Arteris, Inc.'s Chief Operating Officer, Laurent R. Moll, sold 32,775 shares of common stock for approximately $15.42 per share under a pre-arranged 10b5-1 trading plan.

Arteris, Inc.'s VP and General Counsel, Paul L. Alpern, exercised options and subsequently sold 5,000 shares of common stock under a pre-arranged 10b5-1 trading plan.

Arteris, Inc. President and CEO, K. Charles Janac, sold 50,000 shares of common stock for a weighted average price of $13.0742 per share under a pre-arranged 10b5-1 trading plan.

Bayview Legacy, LLC, a 10% owner of Arteris, Inc., sold 50,000 shares of common stock for $13.0742 per share under a pre-arranged 10b5-1 trading plan.

Nicholas B. Hawkins, VP and Chief Financial Officer of Arteris, Inc., sold 6,421 shares of common stock for a weighted average price of $13.2073 per share under a Rule 10b5-1 trading plan.

Arteris, Inc. President and CEO, Janac K Charles, sold over 105,000 shares of common stock for approximately $1.4 million through a pre-arranged 10b5-1 trading plan.

Bayview Legacy, LLC, a 10% owner of Arteris, Inc., sold 100,000 shares of common stock for a weighted average price of $13.1045 per share.

Arteris Director Antonio J. Viana sold 11,841 shares of common stock at $14 per share on October 6, 2025, under a pre-arranged 10b5-1 trading plan.